Pre-, peri-, and postoperative oral administration of branched-chain amino acids for primary liver cancer patients for hepatic resection: A systematic review

Nutrition and Cancer

Volumn 66, Issue 3, 2014, Pages 517-522

  Meng, Jianyuan ^a   Zhong, Jianhong ^a   Zhang, Hanguang ^a   Zhong, Wenhe ^a   Huang, Zhihong ^a   Jin, Yuanming ^a   Xu, Jing ^a  

^a GUANGXI MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BILIRUBIN; BRANCHED CHAIN AMINO ACID; SERUM ALBUMIN;

ABDOMINAL DISTENSION; ABDOMINAL PAIN; ALBUMIN BLOOD LEVEL; ARM CIRCUMFERENCE; BILIRUBIN BLOOD LEVEL; BODY WEIGHT; CANCER MORTALITY; CANCER PALLIATIVE THERAPY; CANCER PATIENT; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CHEMOTHERAPY INDUCED EMESIS; CLINICAL EFFECTIVENESS; DIARRHEA; DRUG EFFICACY; DRUG SAFETY; FOLLOW UP; HUMAN; HYPERTENSION; INTENTION TO TREAT ANALYSIS; KARNOFSKY PERFORMANCE STATUS; LENGTH OF STAY; LIVER CANCER; LIVER RESECTION; META ANALYSIS; MORBIDITY; NAUSEA; NUTRITIONAL STATUS; PERIOPERATIVE PERIOD; PEROPERATIVE CARE; POSTOPERATIVE CARE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SKINFOLD THICKNESS; SYSTEMATIC REVIEW; TREATMENT OUTCOME; BLOOD; LIVER NEOPLASMS; MORTALITY; ORAL DRUG ADMINISTRATION; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD;

ADMINISTRATION, ORAL; AMINO ACIDS, BRANCHED-CHAIN; BILIRUBIN; HUMANS; KARNOFSKY PERFORMANCE STATUS; LENGTH OF STAY; LIVER NEOPLASMS; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; SERUM ALBUMIN; TREATMENT OUTCOME;

EID: 84897406982     PISSN: 01635581     EISSN: 15327914     Source Type: Journal    
DOI: 10.1080/01635581.2013.780628     Document Type: Review

References (21)

1. Bosch FX, Ribes J, Cĺeries R, and D́az M: Epidemiology of hepatocellular carcinoma. Clin Liver Dis 9, 191-211, 2005.
2. Chang CH, Chau GY, Lui WY, Tsay SH, King KL, et al.: Long-term results of hepatic resection for hepatocellular carcinoma originating from the noncirrhotic liver. Arch Surg 139, 320-325, 2004.
3. Neeff H, Makowiec F, Harder J, Gumpp V, Klock A, et al.: Hepatic resection for hepatocellular carcinoma-results and analysis of the current literature. Zentralbl Chir 134, 127-135, 2009.
4. Morris-Stiff G, Gomez D, de Liguori Carino N, and Prasad KR: Surgical management of hepatocellular carcinoma: is the jury still out Surg Oncol 18, 298-321, 2009.
5. Caregaro L, Alberino F, Amodio P, Merkel C, Bolognesi M, et al.: Malnutrition in alcoholic and virus-related cirrhosis. Am J Clin Nutr 63, 602-609, 1996. (Pubitemid 26099255)
6. Plauth M, Cabŕe E, Riggio O, Camilo MA, Pirlich M, et al.: ESPEN Guidelines on enteral nutrition: liver diseases. Clin Nutr 25, 285-294, 2006. (Pubitemid 43811683)
7. Nakaya Y, Okita K, Suzuki K, Moriwaki H, Kato A, et al.: BCAA-enriched snack improves nutritional state of cirrhosis. Nutrition 23, 113-120, 2007. (Pubitemid 46096726)
8. Marchesini G, Bianchi G,Merli M, Amodio P, Panella C, et al.: Nutritional supplementation with branched-chain amino acids in advanced cirrhosis: a double-blind, randomized trial. Gastroenterology 124, 1792-1801, 2003. (Pubitemid 36666776)
9. The San-In Group of Liver Surgery: Long-term oral administration of branched chain amino acids after curative resection of hepatocellular carcinoma: a prospective randomized trial. Br J Surg 85, 1525-1531, 1998.
10. Meng WC, Leung KL, Ho RL, Leung TW, and Lau WY: Prospective randomized control study on the effect of branched-chain amino acids in patients with liver resection for hepatocellular carcinoma. Aust N Z J Surg 69, 811-815, 1999. (Pubitemid 29519301)
11. Okabayashi T, Iyoki M, Sugimoto T, Kobayashi M, and Hanazaki K: Oral supplementation with carbohydrate-and branched-chain amino acidenriched nutrients improves postoperative quality of life in patients undergoing hepatic resection. Amino Acids 40, 1213-1220, 2011.
12. Choi TK, Edward CS, Fan ST, Francis PT, and Wong J: Results of surgical resection for hepatocellular carcinoma. Hepatogastroenterology 37, 172-175, 1990. (Pubitemid 20162250)
13. O'Keefe SJ, El-Zayadi AR, Carraher TE, Davis M, and Williams R: Malnutrition and immuno-incompetence in patients with liver disease. Lancet 2, 615-617, 1980. (Pubitemid 10056650)
14. Moriwaki H, Miwa Y, Tajika M, Kato M, Fukushima H, et al.: Branchedchain amino acids as a protein and energysource in liver cirrhosis. Biochem Biophys Res Commun 313, 405-409, 2004. (Pubitemid 37543600)
15. Blei AT, and Cordoba J: Hepatic encephalopathy. Am J Gastroenterol 96, 1968-1976, 2001. (Pubitemid 32660887)
16. Muto Y, Sato S, Watanabe A, Moriwaki H, Suzuki K, et al.: Effects of oral branched-chain amino acid granules on event-free survival in patients with liver cirrhosis. Clin Gastroenterol Hepatol 3, 705-713, 2005. (Pubitemid 40984733)
17. Takeshita S, Ichikawa T, Nakao K, Miyaaki H, Shibata H, et al.: A snack enriched with oral branched-chain amino acids prevents a fall in albumin in patients with liver cirrhosis undergoing chemoembolization for hepatocellular carcinoma. Nutr Res 29, 89-93, 2009.
18. IkedaY,Kanematsu T, Matsumata T, ShimadaM,Yamagata M, et al.: Liver resection and intractable post-operative ascites. Hepatogastroenterology 40, 14-16, 1993. (Pubitemid 23093916)
19. Kobashi H, Morimoto Y, Ito T, Shimoe T, Makino Y, et al.: Effects of supplementation with a branched-chain amino acid-enriched preparation on event-free survival and quality of life in cirrhotic patients with hepatocellular carcinoma. A multicenter, randomized controlled trial (Abstract). Gastroenterology 130, A497, 2006.
20. Koretz RL,Avenell A, and Lipman TO: Nutritional support for liver disease. Cochrane Database Syst Rev, 16, CD008344, 2002.
21. Kajiwara K, Okuno M, Kobayashi T, Honma N, Maki T, et al.: Oral supplementation with branched-chain amino acids improves survival rate of rats with carbon tetrachloride-induced liver cirrhosis. Dig Dis Sci 43, 1572-1579, 1998. (Pubitemid 28357280)